
Pakistan initiates 'emergency' steps to secure drug supplies after trade suspension with India
The Hindu
Pakistan prepares for pharmaceutical supply chain disruption following trade suspension with India, seeking alternative sources for essential medical supplies.
Pakistani health authorities have initiated "emergency preparedness" measures to secure pharmaceutical supplies in response to the suspension of trade ties with India, according to a media report on Saturday (April 26, 2025).
In response to the India's decision to suspend the Indus Water Treaty following the Pahalgam attack, Islamabad on Thursday suspended all trade with New Delhi among other moves.
Geo News reported that India trade halt triggered "urgent measures to secure" pharmaceutical needs in Pakistan and health authorities have initiated "emergency preparedness" measures to secure the supplies.
The Drug Regulatory Authority of Pakistan (DRAP) has confirmed that while there has been no formal notification regarding the ban's impact on the pharmaceutical sector, contingency plans are already in place, it said.
"Following the 2019 crisis, we had started preparing for such contingencies. We are now actively looking at alternative avenues to meet our pharmaceutical needs," the report quoted a senior DRAP official as saying.
Currently, Pakistan relies on India for 30% to 40% of its pharmaceutical raw materials, including Active Pharmaceutical Ingredients (API) and various advanced therapeutic products.
With this supply chain distributed, DRAP is seeking alternative sources from China, Russia, and several European countries.













